Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma (MEL53)

This study has suspended participant recruitment.
(Study staff out on medical leave)
Sponsor:
Information provided by (Responsible Party):
Craig L Slingluff, Jr, University of Virginia
ClinicalTrials.gov Identifier:
NCT01264731
First received: December 20, 2010
Last updated: September 19, 2013
Last verified: September 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)